Digestive Diseases and Sciences

, Volume 52, Issue 4, pp 1137–1140 | Cite as

Corticosteroid-Responsive Cronkhite-Canada Syndrome Complicated by Thrombosis

  • Joanna E. Sampson
  • Maureen L. Harmon
  • Mary Cushman
  • Edward L. Krawitt
Case Report


Cronkhite-Canada syndrome Polyposis Thrombosis Colon Cancer 



The authors are indebted to Dr. Janice Nicklas of the University of Vermont, Burlington, for searching for mutations of the PTEN gene, to Dr. Michael Manns of the Medizinische Hochschule Hannover, Germany, for performing autoantibody determinations, to Dr. Paul Mayer of the University of Vermont for endoscopy expertise, to Dr. James Vecchio of the University of Vermont for performing and interpreting the capsule endoscopy, and to Dr. Hiroki Takahashi of Jikei University, Tokyo, for researching the Japanese-language literature.


  1. 1.
    Ramsden KL, Thompson H (1994) Cronkhite-Canada syndrome: a seldom recognized entity. Endoscopy 26:331–332PubMedCrossRefGoogle Scholar
  2. 2.
    Nakatsubo N, Wakasa R, Kiyosaki K, Matsui K, Konishi F (1997) Cronkhite-Canada syndrome associated with carcinoma of the sigmoid colon: report of a case. Surg Today 27:345–348PubMedCrossRefGoogle Scholar
  3. 3.
    Bruce A, Ng CS, Wolfsen HC, Smallridge RC, Lookingbill DP (1999) Cutaneous clues to Cronkhite-Canada syndrome: a case report. Arch Dermatol 135:212PubMedCrossRefGoogle Scholar
  4. 4.
    Murata I, Yoshikawa I, Endo M, Tai M, Toyoda C, Abe S, Hirano Y, Otsuki M (2000) Cronkhite-Canada syndrome: report of two cases. J Gastroenterol 35:706–711PubMedCrossRefGoogle Scholar
  5. 5.
    Goo YS, Lee YC, Shin MS, Kim WH, Kim H, Park IS (2001) A case of Cronkhite-Canada syndrome involving the entire gastrointestinal tract. Endoscopy 33:385PubMedCrossRefGoogle Scholar
  6. 6.
    Ward EM, Wolfsen HC (2002) Review article: the non-inherited gastrointestinal polyposis syndromes. Aliment Pharmacol Ther 16:333–342PubMedCrossRefGoogle Scholar
  7. 7.
    Chadalavada R, Brown DK, Walker AN, Sedghi S (2003) Cronkhite-Canada syndrome: sustained remission after corticosteroid treatment. Am J Gastroenterol 98:1444–1446PubMedCrossRefGoogle Scholar
  8. 8.
    Hsu YQ, Loke SL (2003) Cronkhite-Canada syndrome. Gastrointest Endosc 57:917PubMedCrossRefGoogle Scholar
  9. 9.
    Takeuchi Y, Yoshikawa M, Tsukamato N, Shiroi A, Hoshida Y, Enomoto Y, Kimura T, Yamamoto K, Shiiki H, Kikuchi E, Fukui H (2003) Cronkhite-Canada syndrome with colon cancer, portal thrombosis, high titer of antinuclear antibodies, and membranous glomerulonephritis. J Gastroenterol 38:791–795PubMedCrossRefGoogle Scholar
  10. 10.
    Fleisher TA, Strober W, Muchmore AV, Broder S, Krawitt EL, Waldmann TA (1979) Corticosteroid-responsive intestinal lymphangiectasia secondary to an inflammatory process. N Engl J Med 300:605–606PubMedCrossRefGoogle Scholar
  11. 11.
    Obermayer-Straub P, Strassburg CP, Manns MP (2000) Autoimmune hepatitis. J Hepatol 32:181–197PubMedCrossRefGoogle Scholar
  12. 12.
    Burke AP, Sobin LH (1989) The pathology of Cronkhite-Canada polyps; a comparison to juvenile polyposis. Am J Surg Pathol 13:940–946PubMedCrossRefGoogle Scholar
  13. 13.
    van Duijnhoven EM, Lustermans FA, van Wersch JW (1993) Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer. Haemostasis 23:168–172PubMedGoogle Scholar
  14. 14.
    Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T, Grisar J, Machold K, Scholz S, Vogelsang H, Novacek G (2004) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542–548PubMedCrossRefGoogle Scholar
  15. 15.
    Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ (2004) Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 97–101Google Scholar
  16. 16.
    Irving PM, Pasi J, Rampton DS (2005) Thrombosis and inflammatory bowel disease. Clin Gastro Hepatol 3:617–628CrossRefGoogle Scholar
  17. 17.
    Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–155PubMedCrossRefGoogle Scholar
  18. 18.
    Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 343:457–462PubMedCrossRefGoogle Scholar
  19. 19.
    Kamphuisen PW, Eikenboom JC, Bertina RM (2001) Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 21:731–738PubMedGoogle Scholar
  20. 20.
    Seligsohn U, Lubetsky A (2001) Medical progress: genetic susceptibility to venous thrombosis. N Engl J Med 344:1222–1231PubMedCrossRefGoogle Scholar
  21. 21.
    Tsai AW, Cushman M, Rosamund WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR (2002) Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 113:636–642PubMedCrossRefGoogle Scholar
  22. 22.
    Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG (2000) Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 133:81–91PubMedGoogle Scholar
  23. 23.
    Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP (1999) Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in The Caerphilly Heart Study. Br J Haematol 105:110–116PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • Joanna E. Sampson
    • 1
  • Maureen L. Harmon
    • 1
  • Mary Cushman
    • 1
  • Edward L. Krawitt
    • 1
  1. 1.Departments of Medicine and PathologyUniversity of VermontBurlingtonUSA

Personalised recommendations